Background and Purpose-Rates of incident and recurrent cardiovascular events rise steadily with age, due partly to more extensive atherosclerotic burden. However, in patients with similarly severe symptomatic carotid stenosis, increasing age is associated with a greater risk of ipsilateral ischemic stroke. This effect may be due to age-related differences in the pathology of symptomatic carotid plaques. However, previous studies of plaque pathology in relation to age have not accounted for potential confounders, particularly smoking, which is often less prevalent in the elderly population undergoing endarterectomy. Method-We related patient age (Ͻ55, 55 to 64, 65 to 74, 75ϩ years) and smoking habit (never, exsmoker, recent smoker, and current smoker; and number of cigarettes smoked per day) to detailed histological assessments of 526 carotid plaques from consecutive patients undergoing carotid endarterectomy for symptomatic carotid stenosis. Results-Three hundred seventy-nine (72.1%) patients were male (mean/SD age 66.6/8.7). Current/recent smokers were on average 7 years younger at carotid endarterectomy than ex-/never smokers (PϽ0.001), and age at carotid endarterectomy decreased with increasing number of cigarettes smoked per day (P trendϭ0.005). Plaques from current/recent smokers had a lower prevalence of intraplaque hemorrhage (P -trendϭ0.01), but histology was otherwise similar to that in ex-/never smokers, and both groups showed similar changes with age. With increasing age, plaque calcification and large lipid core increased (PϽ0.001 and Pϭ0.01, respectively) and fibrous tissue (Pϭ0.01) decreased, but lymphocyte infiltration of the plaque (Pϭ0.03) and cap (Pϭ0.002) and overall plaque inflammation (Pϭ0.03) also decreased such that overall plaque instability was unrelated to age. Conclusion-Smoking is associated with a lower age at carotid endarterectomy suggesting that it may accelerate the development and/or progression of atherosclerosis. However, the mechanisms of plaque instability seem largely unrelated to smoking. Plaques from younger patients had greater inflammatory cell infiltration, whereas those from older patients had a larger lipid core, but there were no age trends in overall plaque instability suggesting the increased risk of stroke in the elderly with symptomatic carotid stenosis is due to other factors. (Stroke. 2010;41:2288-2294.)
T he incidence of stroke and of acute ischemic events in other vascular territories increases steeply with age. 1 These age trends are due partly to an increased prevalence with age of intermediate phenotypes such as atherosclerosis, but it is also possible that the characteristics of these phenotypes change with age. For example, age Ն75 years is an independent predictor of increased risk of ipsilateral ischemic stroke on medical treatment (and hence benefit from carotid endarterectomy [CEA] ) in patients with similarly severe symptomatic carotid stenosis, 2 and older patients have been found to have an unexpectedly high periprocedural risk of stroke and death due to carotid stenting. 3, 4 One possible explanation for these observations is that carotid plaque instability changes with age.
Two previous histology studies of CEA specimens in relation to patient age have reported conflicting results. The first used a multivariate discriminant analysis in 180 symptomatic plaques and found that older patients tended to have plaques with a high fibrous tissue content. 5 A more recent study found that plaque lipid content increased with age but that there was no change in calcification or macrophage content. 6 However, in that study, asymptomatic and symptomatic plaques were combined in the analyses and no adjustment was made for potentially confounding vascular risk factors such as smoking or hypertension. Because the prevalence of carotid plaques increases with smoking, male sex and adverse lipid profile as well as age, and the effects of these other risk factors are particularly strong at younger ages, 7 any study of plaque pathology in relation to age should consider these as possible interactions. We therefore studied carotid plaque histology in relation to age, smoking, and other vascular risk factors in symptomatic patients undergoing CEA.
Method
We studied consecutive carotid plaques from 526 patients undergoing CEA for symptomatic stenosis in Oxford, UK (the Oxford Plaque Study). The degree of stenosis had been measured using carotid Doppler ultrasound by experienced technicians before surgery. Plaques were considered "symptomatic" if the patient had experienced either an ocular or hemispheric transient ischemic attack or stroke on the side ipsilateral to the carotid stenosis. At the time of the study, it was policy to operate on patients with symptomatic carotid stenosis of Ն70% according to the European Carotid Surgery Trial criteria. 8 Patients undergoing CEA for restenosis or radiotherapyinduced carotid stenosis were excluded.
Our methods for plaque processing and histological assessments have been described elsewhere, 9 -11 but briefly, the excised plaque was fixed in formalin immediately after removal and the portion of carotid bifurcation showing maximum disease was cut transversely. Further divisions were made at 3-mm intervals along the length of the plaque and all sections were embedded in paraffin wax. At the same time in 2003, all 526 plaques were taken and 5-m transverse sections from each wax block were stained with hematoxylin and eosin and Elastin van Gieson and CD68 and CD3 antibody to stain for macrophages and lymphocytes, respectively. A second researcher experienced in vascular pathology examined all the histology sections blind to the clinical details. The following features were graded on simple, reproducible semiquantitative scales as published previously; 9 -11 cap rupture, lipid core size, foam cells, vascularity, plaque and cap infiltration with macrophages and lymphocytes, proportion of fibrous tissue, calcification, intraplaque hemorrhage, and surface thrombus. Briefly, lipid core was defined as amorphous material containing cholesterol crystals and was considered "large" if it occupied Ͼ50% of the thickness of the plaque or Ͼ25% of the total cross-sectional area. Intraplaque hemorrhage was recorded if there was an area of erythrocytes within the plaque causing disruption of plaque architecture or when there was clear evidence of organized hemorrhage with the accumulation of hemosiderin-laden macrophages or iron deposition on plaque connective tissue. 12 Calcification was defined as stippling or calcified nodules. Marked inflammation in the plaque or cap was defined as Ͼ1 group of 20 lymphocytes or 50 macrophages. 9 Cap rupture was recorded if there was clear communication between the lipid core and the lumen with a break in the fibrous cap, which did not appear to have been created during surgery. Surface thrombus was defined as an organized collection of fibrin and red blood cells in the lumen. 13 A plaque with "thin fibrous cap" was defined where the minimum cap thickness was Ͻ200 m as measured using a calibrated graticule in the microscope eyepiece. 11 Plaques were also classified according to the American Heart Association (AHA) classification of coronary atherosclerosis in which Grade 6 represented plaques complicated by hemorrhage, rupture, or thrombus. 14 However, the AHA grade does not take into account important determinants of plaque instability such as lipid core size or inflammation. Thus, those nonruptured plaques with Ն2 other features of marked instability, for example, large hemorrhage, marked inflammation, large lipid core, or thin fibrous cap, were classified as "unstable" as well as all ruptured plaques. 9 This assessment of "overall instability" was based on accepted descriptions of unstable plaque in the coronary circulation. 15 We have previously shown that our histological assessments are reproducible and that there is reasonable agreement between adjacent 3-mm plaque sections. 10 Furthermore, in a study of 128 plaques, we have shown that several histology features (eg, cap rupture, intraplaque hemorrhage, large lipid core, and "unstable plaque") are strongly associated with plaque ulceration on angiography. 9 
Clinical Data Collection
All patients were reviewed before consideration of CEA by a neurologist and the dates, nature, and duration of ipsilateral ischemic episodes were recorded. An event was classified as a stroke if cerebral or retinal ischemic symptoms persisted Ͼ24 hours. The 
Statistical Analyses
Baseline clinical characteristics in age subgroups were compared using an unpaired t test or 2 tests as appropriate. A binary logistic regression model was used to determine the significance of trend for the prevalence of histology features to change with increasing age and worsening smoking habit. We determined age-related trends in histology features for smokers and nonsmokers separately. SPSS (Version 14.0) was used for the analyses.
Results
Patients were operated a median of 85 days (interquartile range, 34 to 150 days) after their most recent symptomatic ischemic event, which was a stroke in 159 (30.2%) and a transient ischemic attack in 367 (69.8%). Three hundred seventy-nine patients (72.1%) were male (mean/SD age 66.6/8.7) and the mean/SD stenosis of the operated artery was 80.7% (16.8) . Four hundred eighty-two patients (91.6%) were on antithrombotic therapy at the time of surgery and 67 (12.7%) were on dual antiplatelet agents (Table 1) . Three hundred three (57.6%) were on treatment for hypertension, 120 (23%) were on lipid-lowering therapy, and 53 (10.1%) were diabetic. Two hundred nine patients (39.7%) were current or recent smokers. Only 85 patients (16.2%) had never smoked.
Fifty-four (10.2%) patients were aged Ͻ55 years, 151 (28.7%) were 55 to 64, 231 (43.9%) were 65 to 74, and 90 (17.1%) were aged Ն75 years. The prevalence of male sex, diabetes, and the nature (stroke versus transient ischemic attack) and timing of most recent ischemic symptoms before CEA did not differ across the age subgroups ( Table 1 ). The prevalence of treated hypertension increased with age (Pϭ0.01) as did the use of dual antiplatelet agents (Pϭ0.04), but a history of smoking within the previous 6 months decreased markedly with age (63.0% (age Ͻ55 years) versus 60.9% (55-64 years) versus 29.9% (65-74 years) versus 15.6% (Ն75 years; P trend Ͻ0.001). Smokers were on average 7 years younger at CEA than nonsmokers (mean age 62.6 versus 69.2 years, PϽ0.001). Furthermore, mean age at CEA decreased with rising daily cigarette consumption in the smokers (P trendϭ0.005; Table 2 ).
With increased smoking, the prevalence of intraplaque hemorrhage decreased (P trendϭ0.01). However, other histology features, for example, plaque inflammation (Pϭ0.72), large lipid core (Pϭ0.61), and unstable plaque (Pϭ0.73), were not associated with smoking habit (Table 3) . Furthermore, in patients who were current/recent smokers and for whom data on cigarettes smoked/day were available (nϭ154), there were no associations between any of the histology features and increasing daily cigarette consumption, for example, intraplaque hemorrhage (P trendϭ0.97), large lipid core (Pϭ0.14), and "unstable plaque" (Pϭ0.96).
As age of the patients at CEA increased, the prevalence of marked calcification (PϽ0.001) and large lipid core (Pϭ0.01) increased, whereas marked lymphocyte infiltration of the cap and plaque (Pϭ0.002 and 0.03, respectively), marked overall plaque inflammation (Pϭ0.03), and fibrous tissue (Pϭ0.01) decreased (Table 4 ). In contrast, there was no association between the prevalence of marked macrophage infiltration of the plaque (Pϭ0.09) and cap (Pϭ0.54), AHA Grade 6 (Pϭ0.87) or "unstable plaque" (Pϭ0.67), and age. The direction of these age-associated trends in the prevalence of histology features was similar in current/recent smokers and ex-/never smokers, but was particularly marked in current/recent smokers (Table 5) .
Discussion
Previous histology studies of CEA specimens in relation to age have had conflicting results but did not fully account for other vascular risk factors. 5, 6 In the largest carotid plaque histology study to date, we have found that smoking was associated with a lower age at CEA and was therefore a potentially important confounding factor but that the mechanisms of plaque instability appeared to be largely unrelated to smoking. Plaques from younger patients had greater inflammatory cell infiltration, whereas those from older patients had a larger lipid core, but the lack of age trends in overall instability suggests that the increased risk of stroke on medical treatment alone in older patients with symptomatic carotid stenosis is due to other factors.
The negative association between smoking and age at CEA in our study is consistent with evidence that smoking accelerates the development and/or progression of atherosclerosis. The exact mechanisms of this effect are unclear but may involve granulocyte activation, 16 increased levels of fibrinogen, 17 and free-radical induced endothelial injury, 18, 19 all of which have been associated with cigarette smoking. Furthermore, cigarette smoke contains bacterial endotoxin, a potent mediator of inflammation. 20 In our study, smoking was not associated with increased plaque inflammation, but there was a negative association with intraplaque hemorrhage, which may reflect a hypercoagulable state. 17 Nevertheless, the broad similarities between plaques from smokers and nonsmokers and the lack of association between rising daily cigarette consumption and histology features suggest that the overall mechanisms of plaque instability are similar in smokers and nonsmokers.
Advancing age was associated with increased plaque calcification and a large lipid core and decreased infiltration of the plaque and cap with lymphocytes, but the prevalence of "unstable plaque" did not increase with age. Therefore, the increased risk of recurrent stroke in the elderly 2 may not be due to differences in plaque pathology, but may instead be due to other factors such as reduced collateral circulation, impaired cerebral autoregulation, 21 aspirin resistance, 22 or hypertension. 23 Of note, the elderly patients in our study had greater mean blood pressure than younger patients despite a greater use of antihypertensive medication ( Table 1) .
The age-related trends in histology were more striking when analyses were confined to current/recent smokers, but this was probably due to relatively large numbers of patients in the 2 youngest age categories (Ͻ55 and 55 to 64 years) of smokers between which the greatest differences in the prevalence of the histology features were seen. Overall, the age trends in histology features were similar in current/recent smokers and ex-/never smokers.
The increase in plaque calcification with age was not unexpected. In the coronary arteries, calcification on CT, which is a marker of coronary plaque burden 24 and future cardiovascular events, 25 has been found to increase with age. 26 In relation to the carotid bifurcation, a correlation between severe lesion calcification and stroke after stenting has been reported. 27 Taken together with the findings from the lead-in phase of the Carotid Revascularization Endarterectomy versus Stent Trial (CREST), 3 that increased patient age is associated with increased risk of periprocedural stroke, it is therefore possible that age-associated plaque calcification is partly responsible, perhaps by contributing to emboli formation. 28 Future prospective studies of plaque characteristics in relation to stent outcomes may help to clarify this further.
There were several potential limitations to our study. First, data on pack-years of smoking, which might have revealed clearer associations with plaque histology, 29 were not available. However, it is reasonable to assume that the older smokers in our study had accumulated more pack-years than young smokers. A second limitation is that only patients fit enough to undergo CEA were included in our study and patients with severe/fatal strokes would have been systematically excluded. Because stroke mortality increases with age, 1 the effects of such selection bias may have been more marked in the older patients. Third, although the prevalence of carotid stenosis increases with age, the rates of diagnosis and CEA tend to fall in clinical practice, especially in patients Ͼ80 years, 30 which may also have led to some selection bias. Fourth, there was a time lapse between the most recent ischemic symptoms and CEA and we have shown in a previous study that certain histological features decline with time since stroke, especially plaque infiltration with macrophages. 31 However, because the proportion of patients with stroke and the median/interquartile range number of days since most recent ischemic event were similar across the patient age and smoking subgroups, these factors were unlikely to have been a source of bias in the analyses. Fifth, because this was a study of plaque histology, it was necessarily cross-sectional and was therefore subject to potential bias from risk factors we have not accounted for. An alternative way of assessing how plaques change with aging of the patient would be to perform a longitudinal study with serial in vivo plaque imaging over many years. This would allow subjects to act as internal controls and allow risk factor profiles to be more easily monitored, for example, changes in smoking habits with time. However, such a study would have to be extremely large to capture sufficient numbers of patients who go on to develop symptomatic carotid stenosis. Furthermore, because in vivo plaque imaging techniques currently lack the resolution to detect some plaque features (eg, thin fibrous cap and inflammation) reliably, plaques would ideally still have to be harvested at endarterectomy for histological analysis. In conclusion, although smoking may well accelerate the progression of carotid atherosclerosis, the underlying mechanisms of plaque instability appear to be similar in smokers and nonsmokers. In our patient population, plaques did not become more unstable overall with increasing age, suggesting the increased early risk of recurrent stroke in elderly patients with symptomatic carotid stenosis may be due to factors other than plaque instability.
